Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Shares of Vertex Pharmaceuticals Inc. VRTX slid 0.46% to $408.76 Friday, on what proved to be an all-around rough trading ...
Monthly Prescribing Reference21h
FDA Approval Increases Eligibility for Cystic Fibrosis Medication Trikafta
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
Investor's Business Daily on MSN23h
Dow Jones Futures Fall: Small Caps Lead As SoundHound Surges; Nvidia At Key Level
Dow Jones futures fell modestly early Friday, along with S&P 500 futures and Nasdaq futures.The stock market rally shrugged ...